Compositions and Methods For Inhibiting FGF23 Activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240034762A1
SERIAL NO

18043894

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides in one aspect a construct comprising the R2 region of FGF23. In other embodiments, the construct functions as a FGF23 antagonist by blocking FGF23 binding to α-Klotho and cell signaling via FGFR activation. In yet other embodiments, the construct prevents FGFR activation. In yet other embodiments, the construct of the present disclosure can be used to treat diseases or disorders related to FGF23 dysregulation and/or overexpression, such as but not limited to phosphate metabolism disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIV YALENot Provided

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lax, Irit New Haven, US 7 89
Schlessinger, Joseph New Haven, US 74 580
Suzuki, Yoshihisa New Haven, US 111 847

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation